A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...

Consider the following before gently correcting your loved one: The present stage of dementia and your loved one’s ability to process information. Is the behavior connected to dementia, or was it ...

Moderate stage Alzheimer's is the second and longest stage of this brain disease, likely marked by increased forgetfulness, confusion, and trouble speaking.

Foralumab helped to normalize microglial cell activity - tied to Alzheimer's progression - in the mice, leading to signs of better cognition.

Foralumab, an investigational nasal spray being developed by Tiziana Life Sciences, has been cleared by the U.S. Food and Drug Administration (FDA) for expanded use to treat moderate Alzheimer’s ...

In early-stage Alzheimer's, changes in abilities or behavior may be minor and only noticeable to family and close friends. Some symptoms typify this stage.

Columnist Ray Burow clarifies some common misconceptions about Alzheimer's disease, particularly that it's a type of mental illness.

Nearly half of some 200 mild-to-moderate Alzheimer’s patients treated with oral simufilam for one year showed gains in cognitive tests.

For the first time, the beneficial effects of pure maple syrup were included in the natural products that protect brain cells against the neural damage found in patients with Alzheimer’s disease. Dr.

The FDA approved Rexulti (brexpiprazole) as the first therapy in the U.S. for agitation associated with dementia due to Alzheimer’s disease.

Alzheimer’s disease is an irreversible, progressive neurological disorder associated with a gradual decline in mental and physical abilities. It is considered the most common form of dementia. The ...

An FDA advisory committee has unanimously voted that trial data support the clinical benefits of Leqembi for early Alzheimer's disease.